Combination stroke therapy: easy as APC?
Lo
Eng H
EH
D000818:Animals; D023102:Anoikis / Q000187:drug effects; D017209:Apoptosis / Q000187:drug effects; D020520:Brain Infarction / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D020782:Matrix Metalloproteinases / Q000378:metabolism; D051379:Mice; D008954:Models, Biological; D011486:Protein C / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D044463:Receptor, PAR-1 / Q000378:metabolism; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D011486:Protein C; D044463:Receptor, PAR-1; D010959:Tissue Plasminogen Activator; D020782:Matrix Metalloproteinases